Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 1
Submit an article Journal homepage
54
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Unrelated Donor Leukocyte Infusions to Treat Relapse after Unrelated Donor Bone Marrow Transplantation

Jose Leis Bone Marrow and Stem Cell Transplant Program, Oregon Health Sciences University, Portland, OR, USA
&
David L. Porter Bone Marrow and Stem Cell Transplant Program, Division of Hematology-Oncology, 16 Penn Tower, University of Pennsylvania Medical Center, 3400 Spruce Street, Philadelphia, PA 19104, USA
Pages 9-18 | Published online: 01 Jul 2009

  • Mathe, G., Amiel, J., Schwarzenberg, L., Cattan, A. and Schneider, M. (1965) "Adoptive immunotherapy of acute leukemia: Experimental and clinical results". Cancer Res. 25. 1525-1531.
  • Radich. J., Sanders, J., Buckner. C., Martin, P., Petersen, F., Bensinger. W., McDonald, G., Mori, M., Schoch, G. and Hansen, J. (1993) "Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens", J. Clin. Oncol. 11, 304-313.
  • Arcese, W., Goldman, J., D'Arcangelo. E., Schattenberg. A., Nardi, A., Apperley. J., Frassoni, F., Aversa. F., Prentice, H., Ljungman. P., Ferrant. A., Maresi, C., Sayer, H., Niederwieser. D., Arnold, R., Bandini, G., Carreras. E., Parker. A., Frappaz, D., Mandelli, F. and Gratwohl, A. (1993) "Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia". Blood 82. 3211 -3219.
  • Collins, R., Rogers, Z., Bennett, M., Kumar, V., Nikein, A. and Fay. J. (1992) "Hematologic relapse of chronic myelogenous leukemia following allogeneic bone marrow transplantation: apparent graft-versus-lcukemia effect following abrupt discontinuation of immunosuppression". Bone Marrow Transplant. 10. 391-395.
  • Odom, L., August, C., Githens. J. Humbert, J., Morse. H., Peakman, D., Sharma, B., Rusnak, S. and Johnson, F. (1978) "Remission of relapsed leukaemia during a graft-versus-host reaction. A graft-versus-leukaemia reaction in man?". Lancet 2. 537-540.
  • Horowitz. M., Gale, R., Sondel, P., Goldman, J., Dersey, J., Kolb, H., Rimm, A., Ringden, O., Rozman., C., Speck, B., Truitt, R., Zwaan, F. and Bortin. M. (1990) "Graft-versus-leukemia reactions after bone marrow transplantation". Blood 75. 555-562.
  • Gale, R., Horowitz., M., Ash, R., Champlin, R., Goidman, J., Rimm, A., Ringden, O., Veum Stone, J. and Bortin. M. (1994) "Identicaltwin bone marrow transplants for leukemia". Ann. Intern. Med. 120, 646 652.
  • Weiden, P., Sullivan, K., Flournoy, N., Storb, R. and Thomas. E. (1981) "Antileukemic effect of chronic graft-versus-host disease. Contribution to improved survival after allogeneic marrow transplantation'', N. Engl. J. Med. 304, 1529-1533.
  • Apperley, J., Mauro, F., Goldman, J., Gregory, W., Arthur, C., Hows, J., Arcese, W., Papa, G., Mandelli, F., Wardle, D., Gravett, P., Franklin, I., Bandini, G., Ricci, P., Tura, S., lacone, A., Torlontano. G., Heit, W., Champli, R. and Gale, R. (1988) "Bone marrow transplantation for chronic mycloid leukaemia in first chronic phase: importance of a graft-versus-leukaemia effect", Br. J. Haematol. 69. 239-245.
  • Goldman, J., Gale, R., Horowitz, M., Biggs, J., Champlin, R., Gluckman, E., Hoffmann. R., Jacobsen. S., Marmont, A., McGlave, P., Messner, H., Kimm. A., Rozman, C., Speck, B., Tura, S., Weiner, R. and Bortin. M. (1988) "Bone marrow transplantation for chronic myelogenous leukemia in chronic phase". Ann. Intern. Med. 108, 806-814.
  • Mrsic, M., Horowitz, M., Atkinson, K., Biggs. J. Champlin. R., Ehninger, G., Gajewski, J., Gale. R., Herzig, R., Prentice. H., Rozman, C., Sobocinski. K., Speck. B. and Bortin. M. (1992) "Second HLA-identical sibling transplants for leukemia recurrence". Bone Marrow Transplant. 9. 269-275.
  • Wagner, J.E., Vogelsang, G.B., Zehnbauer, B.A., Griffin, C.A., Shah. N. and Santo, G.W. (1992) "Relapse of leukemia after bone marrow transplantation: effect of second myeloablative therapy", Bone Marrow Transplant. 9, 205-209.
  • Kolb, H., Mittermuller, J., Clemm, C., Holler, E., Ledderose, G., Brchm, G., Heim, M. and Wilmanns, W. (1990) "Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients". Blood 76, 2462-2465.
  • Porter, D., Roth, M., McGarigle, C., Ferrara. J and Antin. J. (1994) "Induction of graft-versus-host disease an immunotherapy for relapsed chronic mycloid leukemia", N. Engl. J. Med. 330, 100-106.
  • Orobyski, W., Keever, C., Roth, M., Koethe, S., Hanson. G. McFadden. P., Gottschall, J., Ash, R., van Tuinen, P., Horowitz, M. und Flomenherg, N. (1993) "Salvage immunotherapy, using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and loxicity of a defined T-cell dose". Blood 82. 2310-2318.
  • Hertenstein, B., Wiesneth, M., Novolny, J., Bunjes, D, Stefanie, M., Heinze, B., Hubner, G., Heimpel, H. and Arnold, R. (1993) "Interferon-a and donor buffy coat transfusions for treatment of relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation". Transplantation 56. 1114- 1118.
  • Mackinnon, S., Hows, J, and Goldman, J. (1990) "Induction of in vitro graft-versus-leukemia activity following bone marrow transplantation for chronic myeloid leukemia". Blood 76. 2037-2045.
  • Slavin, S., Naparstek, E., Nagler, A., Ackerstein, A., Samuel, S., Kapelushnik, J., Brautbar, C. and Or, R. (1996) "Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation". Blood 87. 2195-2204.
  • Van Rhee, F., Lin, F., Cullis, J., Spencer, A., Cross, N., Chase, A., Garicochea, B., Bungey, J., Barrett, J. and Goldman, J. (1994) "Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case forgiving donor leukocyte transfusions before the onset of hematologic relapse". Blood 83. 3377-4383.
  • Collins, R., Shpilberg, O., Drobyski, W., Porter, D., Giralt, S., Champlin. R., Goodman, S., Wolff, S., Hu. W., Verfaillie, C., List. A., Dalton, W., Ognoskie, N., Chetrit A., Antin, J. and Nemunaitis, J. (1997) "Donor leukocyte infusions in 140 patients with relapsed maliqnancy after allogeneic bone marrow transplantation", J. Clin. Oncol. 15, 433-444.
  • Roth, M., Antin, J., Bingham, E. and Ginsberg, D. (1989) "Detection of Philadelphia chromosome-positive cells by the polymerase chain reaction following bone marrow transpant for chronic myelogenous leukemia". Blood 74. 882 885.
  • Kolb, H., Schattenberg. A., Goldman, J., Hertenstein, B., Jacobsen. N., Arcese. W., Ljungman, P., Ferrant. A., Verdonck. L., Niederwieser, D., van Rhee. F., Mittermueller, J., de Witte, T., Holler, E. and Ansari. H. (1995) "Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients". Blood 86. 2041 -2050.
  • Kolb, H., Mittermuller, J. Hertenstein, H., Schumm, M., Holler, E., de Witte, T., Gunther, W., Ljungman, P. and Goldman. J. (1993) "Adoptive immunotherapy in human and canine chimeras the role of Interferon alfa", Sem Hematol. 30. 37-39.
  • Porter, D., Collins, R., Drobyski, W., Connors. J., Van Hoef, M. and Antin, J. (1997) "Long-term follow-up of 55 patients who achieved complete remission (CR) after donor leukocyte infusions (DLI) for relapse after allogeneic bone marrow transplantation (BMT)", Blood 90, 549a.
  • Dazzi, F., Szydlo, R.M., Cross, N.C., Craddock, C., Kaeda, J., Kanfe, E., Cwynarski, K., Olavarria, E., Yong, A., Apperley, J.F. and Goldman. J.M. (2000) "Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia". Blood 96, 2712-2716.
  • Porter, D., Roth, M., Lee. S., McGarigle, C., Ferrara, J. and Amtin, J. (1996) "Adoptive immunotherapy with donor mononuclear cell infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic hone marrow transplantation". Bone Marrow Transplant. 18. 975-980.
  • Szer, J., Grigg, A., Phillipos, G. and Sheridan, W. (1993) "Donor leucocyte infusions after chemotherapy for patients relapsing with acute leukaemia following allogeneic BMT", Bone Marrow Transplant 11, 109-111.
  • Levine, J., Braun, T., Penza, S., Bcatty, P., Cornetta, K., Martino, R., Drobyski. W., Barrett, A., Porter, D., Giralt, S., Horowitz, M., Leis, J., Johnson, M. and Collins, R. (2001) Chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies following allogeneic stem cell transplantation. J. Clin. Oncol., In Press.
  • Collins, Jr., R.H., Goldstein. S., Girali, S., Levine. J., Porter. D., Drobyski, W., Barrett, J., Johnson, M., Kirk, A., Horowitz. M. and Parker, P.(2000) "Donor leukocyte infusions in acute lymphoeytic leukemia". Bone Marrow Transplant. 26. 511-516.
  • Tricot, G., Vesole, D., Jagannath, S., Hilton. J., Munshi, N. and Barlogic. B. (1996) "Graft-versus-myeloma effect: proof of principle", Blood 87. 1196-1198.
  • Lokhorst, H.M., Schattenberg, A., Cornelissen, J.J., Thomas, L.L. and Verdonek, L.F. (1997) "Donor leukocyte infusions arc effective in relapsed multiple myeloma after allogeneic bone marrow transplantation". Blood 90, 4206-4211.
  • Lokhorst, U.M., Schattenberg, A., Comelissen, J.J., van Oers, M.H., Fibbe, W., Russell, I., Donk, N.W. and Verdonck, L.F. (2000) "Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: predictive factors for response and long-term outcome", J. Clin. Oncol. 18. 3031 - 3037.
  • Salama, M., Nevill, T. Marccllus, D., Parker, P., Johnson. M., Kirk. A., Porter, D., Giralt, S., Levine. J., Drobyski, W., Bairett. A., Hurowitz, M. and Collins. R. (2000) "Donor leukocyte infusions for multiple myeloma", Bone Marrow Transplant. 26. 1179-1184.
  • Ratanatharathorn, V., Uberti, J., Karanes. C., Abella, E., Lum, L.G., Momin, F., Cummings, G. and Sensenbrenner. L.L., (1994) "Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin s lymphoma". Blood 84, 1050-1055.
  • Jones, R., Ambinder. R., Piantadosi, S. and Santos, G. (1991) "Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation". Blood 77, 649 653.
  • van Besien, K., de Lima. M., Giralt, S., Moore. D., Khouri, L., Rondon. G., Mehra, R., Anderson. B.,Dyer. C., Cleary, K.,Przepiorka, D., Gajewski, J. and Champlin, R. (1997) "Management of lymphoma recurrence after allogeneic transplantation: the relevance of, graft-versus-lymphoma effect". Bone Marrow Transplant. 19. 977-982.
  • Russell, L., Jacobsen, N., Heilmann, C., Simonsen, A.C., Christensen. L.D. and Vindelov, L.L. (1996) "Treatment of relapse after allogeneic BMT with donor leukocyte infusions in 16 patients". Bone Marrow Transplant. 18. 411-414.
  • Mackinnon, S., Papadppoulos, E., Carabasi, M., Reich, L., Collins. N., Boulad, F., Custro-Malaspina, H. Childs, B., Gillio, A., Kernan, N., Small, T., Young, J. and O'Reilly, R. (1995) "Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease". Blood 86. 1261-1268.
  • Keil, R. Haas, O.A., Fritsch, G., Kalhs. P., Lechner, K., Mannhalter, C., Reiter, E., Niederwieser. D., Hoecker, P. and Greinix. H.T. (1997) "Donor leukocyte infusion for leukemic relapse after allogeneic marrow transplantation, lack of residual donor hematopoiesis predicts aplasia". Blood 89. 3113-3117.
  • Siegert, W., Beyer, J., Kingreen, D., Blasczyk, R., Baurmann. H., Schwella. N., Schleicher. J., Kirsch. A. and Huhn. D. (1998) 'Treatment of relapse after allogeneic bone marrow transplantation with unmanipulated G-CSF-mobilized peripheral blood stem cell preparation". Bone Marrow Transplant. 22. 579-583.
  • Flowers, M., Leisenring, W., Beach. K., Riddell, S., Radich, J., Higano, C., Rowley. S., Chauncey, T., Bensinger, W., Sanders. J., Anasetti, C., Storb, R., Wade, J., Appelbaum. F. and Martin, P. (2000) "Granulocyte colony-stimulating factor given to donors before apheresis does not prevent aplasia in patients treated with donor leukocyte infusion for recurrent chronic myeloid leukemia after bone marrow transplantation". Biol. Blood Marrow Transplant. 6. 321 326.
  • Pan, L., Delmonte, J., Jalonen, C. and Ferrara. L. (1995) "Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental (graft-versus-host disease". Blood 86. 4422 -4429.
  • Porter, D., Collins, R., Hardy. C., Kernan, N., Drobyski. W., Giralt, S., Flowers, M., Casper. J., Leahey, A., Parker. P., Mick. R., BateBoyle, B., King, R. and Antin, J. (2000) "Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions". Blood 95. 1214-1221.
  • van Rhee, R., Savage. D., Blackwell, J., Orchard. K., Dazzi. K. Lin. F., Chase, A., Bungey, J., Cross, N., Apperley, J., Szydlo, R. and Goldman, J. (1998) "Adoptive immunotherapy for relapse of chronic myeloid leukemia after allogeneic hone marrow transplant: equal efficacy of lymphocytes from sibling and matched unrelated donors". Bone Marrow Transplant. 21. 1055-1061.
  • Porter, D. and Antin, J. (1997) "Adoptive immunotherapy in bone marrow transplantation", In: Burakoff, S., Deeg, H. and Ferrara, J., (Eds). Graft-versus-Host-Disease (New York: Marcel Dekker), pp. 733 754.
  • Bhatia, V. and Porter, D. (2001) "Novel approaches to allogeneic stem cell therapy". Exp. Opin. Biol. Threapy 1,3-15.
  • Champlin, R., Khouri. L., Komblau, S., Molidrem. J. and Giralt, S. (1999) "Reinventing bone marrow transplantation. Nonmycloablative preparative regimens and induction of graft-vs-malignancy effect". Oncology (Huntingt) 13, 621 -628, discussion 631. 635-628,641.
  • Slavin, S., Nagler. A., Naparstek, E., Kapelushnik, Y., Aker, M., Cividalli, G., Varad, G., Kirschbaum, M., Ackerstein, A., Samuel, S., Amar, A., Brautbar, C., Bel-Tal, O., Eldor, A. and Or, R. (1998) ``Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases", Blood 91. 756-763.
  • Levine, J., Penza, S., Topolsky, D., Beatty, P., Rifkin, R., Giralt, S., Porter, D., Drobyski, W., Horowitz. M. and Collins, R.H. (1999) "Prospective trial of chemotherapy plus donor leukocyte infusions (DLI) to treat relapsed advanced myeloid leukemia after related hone marrow transplantation (BMT)", Blood 94.
  • Varadi, G., Ackerstein, A., Ben-Neriah, S. and Nagler, A. (1998) "Adoptive cell-mediated immunotherapy with interleukin-2 (IL-2) for relapsing lymphoblastic crisis following mismatched unrelated bone marrow transplantation in a chronic myelogenous leukemia patient". Bone Marrow Transplant. 21. 93- 96.
  • Verdonck, L.F., Petersen, E.J., Lokhorst, H.M., Nieuwenhuis, H.K., Dekker. A.W., Tilanus, M.G. and de Weger, R.A. (1998) "Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells". Hone Marrow Transplant. 22. 1057-1063.
  • Giralt, S., Hester, J., Hub. Y., Hirsch-Ginsberg, C., Rondon, G., Seong, D., Lee. M. Gajcwski. J., Van Besien. K., Khouri. I., Mehra. R. Przepiorka, D., Korbling. M., Talpaz., M., Kantarjian, H., Fischer, H. Deisseroth, A. and Champlin, R. (1995) "CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myclogenous leukemia after allogeneic hone marrow transplantation". Blood 86, 4337-4343.
  • Mehta, J., Powles, R., Treleaven, J., Horton, C. Meller, S., Pinkerton, C. and Singhal, S. (1997) "Outcome of acute leukemia relapsing after bone marrow transplantation: utility of second transplants and adoptive immunotherapy". Bone Marrow Transplant. 19. 769-719.
  • Mehta, J., Powles, R., Singhal, S., Tail, D., Swansbury, J. and Treleaven, J. (I995) "Cytokine-mediated immunotherapy with or without donor leukocytcs for poor-risk acute myeloid leukemia relapsing after allogeneic bone marrow transplantation". Bone Marrow Transplant. 16. 133-137.
  • Mackinnon, S., Papadopoulos, E., Carabasi, M., Reich, L., Collins, N. and O'Reilly, R. (1995) "Adoptive lmmunotherapy using donor leukocytes following bone marrow transplantation for chronic myeloid leukemia: is T cell dose important in determining biological response?". Bone Marrow Transplant. 15, 591 -594.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.